DEANTA NORMAN: Open Payments
NPI 1972929651 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$728 in 63 payments from 15 companies in 2025. Trend: 2023 $14 · 2024 $293 · 2025 $728
Food & beverage: $728
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 33 | $241 |
| Corium, LLC | 10 | $97 |
| Collegium Pharmaceutical, Inc. | 5 | $77 |
| SANOFI PASTEUR INC. | 2 | $54 |
| LNHC, Inc | 2 | $53 |
| Noven Therapeutics, LLC | 2 | $36 |
| Cipher Pharmaceuticals US LLC | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| PFIZER INC. | 1 | $20 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $19 |
Products named: Qelbree, Azstarys, Jornay PM, ZELSUVMI, Xelstrym, BEYFORTUS, MENQUADFI, Natroba.
Industry payments across LA — which companies pay providers there.
